Project Grant R01AG096522
- The National Institute on Aging awarded New York University $3.053 million on September 1, 2026, under the Aging Research program (CFDA 93.866) to conduct longitudinal research on caregiving networks and their consequences among adults ages 85 and older. The award funds the ARIC CARES study, embedded within the Atherosclerosis Risk in Communities Study cohort. The research will characterize care ecosystems and relational coordination (teamwork) among family caregivers, paid caregivers, and...
- The National Institute on Aging awarded $156,000 to the University of Texas Health Science Center at Houston on September 1, 2026, under the Aging Research program (CFDA 93.866) to generate a theoretical model of family caregivers' decision-making around medication administration for behavioral symptoms of dementia. The recipient will conduct constructivist grounded theory research through in-depth interviews with 35 family caregivers of persons with Alzheimer's disease or related dementia,...
- The National Institute on Aging awarded the University of Texas Health Science Center at Houston $312,000 on September 1, 2026, under the Aging Research program (CFDA 93.866) to revise and validate the Caregiver-Provider Relationship Assessment (CPRA), a measurement tool designed to evaluate interactions between family caregivers of individuals with Alzheimer's disease and related dementias and healthcare providers. The project will develop a psychometrically validated revision of the CPRA using...
- The National Institute on Aging awarded New York University $6.203 million on September 15, 2025, under the Aging Research program (CFDA 93.866) to examine peripheral immune markers and vascular dysfunction as contributors to cognitive decline and Alzheimer's disease. The research integrates circulating biomarkers—platelet aggregation, neutrophil activity, and proteomic data—with advanced imaging to assess associations between vascular and immune dysfunction and cerebrovascular burden, amyloid...
- The National Institute on Aging awarded the University of Texas at Austin $10.686 million on September 15, 2025, under the Aging Research program (CFDA 93.866) to investigate remotely-supervised neuromodulation paired with language treatment for the logopenic variant of primary progressive aphasia, a progressive language disorder caused by underlying Alzheimer's disease pathology. The award supports research to enhance proven language treatment for LVPPA by combining it with tailored, home-based...
- The National Institute on Aging awarded The University of Texas Health Science Center at San Antonio $326,040 on September 9, 2025, under the Aging Research program (CFDA 93.866) to support research bridging gaps in plasma Alzheimer's disease and related dementias biomarkers for diverse populations. The project will identify demographic, lifestyle, genetic, and systemic disease factors associated with elevated plasma biomarkers in population cohorts in the United States and Uganda; assess the...
- The National Institute on Aging awarded the National Opinion Research Center $2.489 million on September 1, 2026, under the Aging Research program (CFDA 93.866) for a project grant (R01AG102939) titled "NSHAP Caregiver Study — Networks, Experiences, and Health Outcomes Across the Life Course." The recipient will conduct a comprehensive follow-up study of caregivers participating in Round 5 of the National Social Life, Health, and Aging Project. The project will collect original data...
- The National Institute on Aging awarded The University of Texas Health Science Center at San Antonio $1.112 million on September 20, 2025, under the Aging Research program (CFDA 93.866) to deliver advanced training in cross-national research on cognitive aging and Alzheimer's disease and related dementias using harmonized datasets from the Health and Retirement Study and the Harmonized Cognitive Assessment Protocol. The award funds five annual intensive courses for advanced-doctoral,...
- The National Institute on Aging awarded The University of Chicago $597,239 on September 1, 2026, under the Aging Research program (CFDA 93.866) to support investigation of inpatient rehabilitation facility (IRF) utilization and outcomes for older adult patients with and without Alzheimer's disease or other dementias (ADRD). The research examines comparative value and appropriateness of care delivery across post-acute care settings, specifically comparing higher-cost IRF care—which provides acute...
- The National Institute on Aging awarded Texas A&M University $640,059 on September 1, 2026, under the Aging Research program (CFDA 93.866) to investigate cerebellar changes in aging and cognitive decline through longitudinal neuroimaging and functional analysis. The project examines how cerebellar structure, white matter circuits, and task-based functional activation change over time in older adults, with particular focus on individuals experiencing subjective cognitive decline—self-reported...
The National Institute on Aging awarded the University of Texas at Austin $650,447 on September 1, 2026, under the Aging Research program (CFDA 93.866) to develop a profile-based framework for matching transitional care services to distinct patient-caregiver groups among persons living with dementia (PLWDs). The award funds research to identify patient-caregiver profiles and co-develop provider and system implementation tools that enable tailored, evidence-based transitional care delivery across diverse healthcare settings. The project will examine individual transitional care service components to determine which services benefit which PLWD-caregiving profiles, moving beyond one-size-fits-all approaches that currently fail to meet the needs of the 7.2 million Americans living with dementia. Persons with mild-to-moderate dementia will serve as active co-designers throughout toolkit development. Using mixed-methods and community-based participatory research strategies across three Texas hospitals, the research will identify PLWD-caregiving profiles through theory-driven and data-driven approaches, examine how transitional care service receipt and outcomes vary across profiles, and assess stakeholder needs and implementation barriers. Performance occurs in Austin, Texas, with a period of performance from September 1, 2026, through June 30, 2030. The award is structured as a Project Grant, an assistance type under the National Institute on Aging's mission to support biomedical and behavioral research on aging and aging-related diseases.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $650.4k | 8/25/26 |